Andrés J. Munoz Martin: What are the main take-home messages from “Mortality impact of cancer-associated venous thromboembolism: Final analysis from Oncothromb12-01 study” session and what are the key elements you think should be shared?
Cliona Kirwan: What are the main take-home messages from “Hemostatic complications and novel anti-cancer therapies” session and what are the key elements you think should be shared?
Rupert Bauersachs: What are the main take-home messages from “Outcomes of cancer-associated isolated superficial vein thrombosis in daily practice” session and what are the key elements you think should be shared?